Search

Your search keyword '"Pfaar, Oliver"' showing total 1,277 results

Search Constraints

Start Over You searched for: Author "Pfaar, Oliver" Remove constraint Author: "Pfaar, Oliver"
1,277 results on '"Pfaar, Oliver"'

Search Results

2. Impact of Allergic Rhinitis Control on Work Productivity and Costs: A Real-World Data MASK-air Study

3. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

5. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

7. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

8. Intranasal Versus Oral Treatments for Allergic Rhinitis: A Systematic Review With Meta-Analysis

12. Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study

14. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

15. Cutoff Values of MASK-air Patient-Reported Outcome Measures

17. Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study

18. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

19. POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project.

23. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

24. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

25. Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis

26. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

29. Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real-life

30. Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real-life

31. Hot topics in allergen immunotherapy, 2023: Current status and future perspective

32. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

33. Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper.

34. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

35. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

37. Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE)

38. Anaphylaxie-Risiko bei der COVID-19-Impfung: Empfehlungen für das praktische Management

39. Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper

40. Obituary: Professor Marcus Maurer, Berlin, Germany.

42. Therapy of allergic rhinitis in routine care: evidence-based benefit assessment of freely combined use of various active ingredients: A position paper of the Medical Association of German Allergists (AEDA) in cooperation with the ENT section of the European Academy of Allergy and Clinical Immunology (EAACI), the German ARIA (Allergic Rhinitis and its Impact on Asthma) Group and the Working Group Clinical Immunology, Allergology and Environmental Medicine of the German Society for Otorhinolaryngology, Head and Neck Surgery (DGHNO-KHC)

43. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

44. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

46. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

48. Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper.

49. Hot topics in allergen immunotherapy, 2023: Current status and future perspective.

50. Hot topics in allergen immunotherapy, 2023: Current status and future perspective

Catalog

Books, media, physical & digital resources